An observational study in Aging, sponsored by Hopital Lariboisière. Completed at 2 sites in France. Open to participants aged 40 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2010-09-14.
Sponsored by Hopital Lariboisière · Observational
Aging is an independent risk factor, without any clear explanation. The primary aim of the study is to depict the effect of aging on the coagulation fibrinolysis parameters and microparticles.
Patients older than 40, without any acute disease and not receiving any antiaggregant and anticoagulant therapy will be included in the study. Blood tests will be performed for coagulation, fibrinolysis and microparticles measurement.
Hopital Lariboisière is the lead sponsor of 29 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Stable patients without overt acute clinical event, not receiving antiplatelet or anticoagulant treatment
Exclusion Criteria:
This study is completed, as verified in Sep 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hopital Lariboisière